Serum DLK1 During Minipuberty and Pubertal Transition in Healthy Girls and in Girls With Precocious Puberty
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae762 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Lea Vilmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen, DK-2100, Denmark. Hauptthemen laut MEDLINE: Puberty, Precocious, Calcium-Binding Proteins, Puberty, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Capital Region of Denmark, Kirsten and Freddy Johansen Foundation, International Center for Research and Research Training in Endocrine Disrupting Effects of Male Reproduction and Child Health (EDMaRC).
Abstract (Originalsprache)
Context
Delta-like non-canonical notch ligand 1 (DLK1) is negatively associated with bodyweight. DLK1 pathogenic variants cause central precocious puberty (CPP) and obesity, suggesting that DLK1 links the well-established association between higher body mass index and earlier pubertal onset. However, little is known about the trajectories of circulating DKL1 in healthy girls as well as in girls with precocious puberty.
Objective
To evaluate longitudinal changes in circulating DLK1 concentrations in (1) full-term, singleton healthy infant girls, (2) healthy girls during pubertal transition, and (3) girls with CPP during treatment with gonadotropin-releasing hormone agonist (GnRHa).
Methods
Three longitudinal studies of (1) healthy infant girls (n = 85), (2) healthy peripubertal girls (n = 15), and (3) girls with CPP before and after GnRHa treatment (n = 15). Body fat percentage calculated using the Slaughter equation, and serum concentrations of DLK1 using enzyme-linked immunosorbent assay.
Results
Serum concentration of DLK1 in healthy infant girls declined significantly through the first year of life (17.6 to 9.9 ng/mL, P = .020). DLK1 was inversely correlated with birth weight and BF%: r = −0.220, P = .044, and r = −0.503, P < .001, respectively. DLK1 declined from 1 year prior to pubertal onset to time of first examination after pubertal onset (10.4 to 9.2 ng/mL, P = .004), as well as to time at the last pubertal evaluation (10.4 to 9.8 ng/mL, P = .006). DLK1 levels were not affected by GnRHa treatment.
Conclusion
Circulating DLK1 levels declined steeply during infancy and were less pronounced through pubertal development. Due to considerable interindividual variation, DLK1 is not useful as a diagnostic marker of pubertal onset. Importantly, DLK1 was negatively associated with birth weight and body fat percentage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen, DK-2100, Denmark.
- The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, DK-2100, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, DK-2100, Denmark.
ORCID-Profile: Lea Vilmann, Anders Juul
Förderung
- Capital Region of Denmark
- Kirsten and Freddy Johansen Foundation
- International Center for Research and Research Training in Endocrine Disrupting Effects of Male Reproduction and Child Health (EDMaRC)
Zitieren
APA
Vilmann, L., Sørensen, K., Busch, A. S., Ljubicic, M. L., Upners, E. N., Fischer, M. B., Johannsen, T. H., Holmboe, S. A., Juul, A., & Hagen, C. P. (2025). Serum DLK1 During Minipuberty and Pubertal Transition in Healthy Girls and in Girls With Precocious Puberty. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae762
Vancouver
Vilmann L, Sørensen K, Busch AS, Ljubicic ML, Upners EN, Fischer MB, et al. Serum DLK1 During Minipuberty and Pubertal Transition in Healthy Girls and in Girls With Precocious Puberty. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae762
BibTeX
@article{Vilmann2025,
author = {Vilmann, Lea and Sørensen, Kaspar and Busch, Alexander S and Ljubicic, Marie L and Upners, Emmie N and Fischer, Margit B and Johannsen, Trine H and Holmboe, Stine A and Juul, Anders and Hagen, Casper P},
title = {Serum DLK1 During Minipuberty and Pubertal Transition in Healthy Girls and in Girls With Precocious Puberty},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae762}
}
EUVIMED